{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:18:00Z","timestamp":1787883480745,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07171-0","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:49:57Z","timestamp":1781779797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of belimumab in children with systemic lupus erythematosus"],"prefix":"10.1186","volume":"26","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianji","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaonan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"11","key":"7171_CR1","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1177\/09612033211028653","volume":"30","author":"RA Levy","year":"2021","unstructured":"Levy RA, Gonzalez-Rivera T, Khamashta M, et al. 10 years of belimumab experience: what have we learnt? Lupus. 2021;30(11):1705\u201321.","journal-title":"Lupus"},{"key":"7171_CR2","doi-asserted-by":"publisher","first-page":"108907","DOI":"10.1016\/j.clim.2021.108907","volume":"234","author":"T Alexander","year":"2022","unstructured":"Alexander T, Hedrich CM. Systemic lupus erythematosus - are children miniature adults? Clin Immunol. 2022;234:108907.","journal-title":"Clin Immunol"},{"issue":"6","key":"7171_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/1756-185X.13547","volume":"22","author":"CX Zhang","year":"2019","unstructured":"Zhang CX, Cai L, Zhou ZY, et al. Clinical manifestations, immunological features and prognosis of Chinese pediatric systemic lupus erythematosus: a single-center study. Int J Rheum Dis. 2019;22(6):1070\u20136.","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"7171_CR4","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1177\/09612033211045050","volume":"30","author":"T Giani","year":"2021","unstructured":"Giani T, Smith EM, Al-Abadi E, et al. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: data from the UK Juvenile-onset systemic lupus erythematosus cohort study. Lupus. 2021;30(12):1955\u201365.","journal-title":"Lupus"},{"issue":"6","key":"7171_CR5","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.5114\/aoms\/153469","volume":"18","author":"Q Jiang","year":"2022","unstructured":"Jiang Q, Li RX, Hu P. Raynaud\u2019s phenomenon in childhood-onset systemic lupus erythematous. Arch Med Sci. 2022;18(6):1716\u20137.","journal-title":"Arch Med Sci"},{"issue":"22","key":"7171_CR6","doi-asserted-by":"publisher","first-page":"E805","DOI":"10.1503\/cmaj.202246","volume":"193","author":"J Coulombe","year":"2021","unstructured":"Coulombe J, Barsalou J. Neonatal lupus presenting as a butterfly rash. CMAJ. 2021;193(22):E805.","journal-title":"CMAJ"},{"issue":"2","key":"7171_CR7","first-page":"135","volume":"30","author":"E Kontaxi","year":"2019","unstructured":"Kontaxi E, Trachana M, Pratsidou-Gertsi P, et al. Paediatric acute respiratory distress syndrome as the introductory manifestation in a patient with childhood onset systemic lupus erythematosus. Mediterr J Rheumatol. 2019;30(2):135\u20138.","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"7171_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semarthrit.2020.12.004","volume":"51","author":"DA Papachristos","year":"2021","unstructured":"Papachristos DA, Oon S, Hanly JG, et al. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum. 2021;51(1):49\u201371.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"7171_CR9","first-page":"172","volume":"59","author":"Chinese Rheumatology Association, National Clinical Research Center for Dermatologic and Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment and Research Group","year":"2020","unstructured":"Chinese Rheumatology Association, National Clinical Research Center for Dermatologic and Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment and Research Group. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Chin J Intern Med. 2020;59(3):172\u201385.","journal-title":"Chin J Intern Med"},{"issue":"12","key":"7171_CR10","first-page":"1009","volume":"59","author":"XM Tang","year":"2021","unstructured":"Tang XM, the Society of Pediatrics, Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of childhood-onset systemic lupus erythematosus (2021 edition). Chin J Pediatr. 2021;59(12):1009\u201317.","journal-title":"Chin J Pediatr"},{"key":"7171_CR11","doi-asserted-by":"publisher","first-page":"966809","DOI":"10.3389\/fimmu.2022.966809","volume":"13","author":"CH Wu","year":"2022","unstructured":"Wu CH, Chen CA, Lin SH, et al. Increased risk of early-onset childhood systemic lupus erythematosus for children born to affected parents: a nationwide child-parent cohort study. Front Immunol. 2022;13:966809.","journal-title":"Front Immunol"},{"issue":"1","key":"7171_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/acr.25443","volume":"77","author":"WD Soulsby","year":"2025","unstructured":"Soulsby WD, Olveda R, He J, et al. Racial disparities and achievement of the low lupus disease activity state: a CARRA registry study. Arthritis Care Res (Hoboken). 2025;77(1):38\u201349.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"7171_CR13","first-page":"583","volume":"42","author":"D Schilir\u00f2","year":"2024","unstructured":"Schilir\u00f2 D, Silvagni E, Cirib\u00e8 B, et al. Systemic lupus erythematosus: one year in review 2024. Clin Exp Rheumatol. 2024;42(3):583\u201392.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"7171_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0961203316660625","volume":"26","author":"LB Lewandowski","year":"2017","unstructured":"Lewandowski LB, Schanberg LE, Thielman N, et al. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa. Lupus. 2017;26(2):186\u201394.","journal-title":"Lupus"},{"issue":"6","key":"7171_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"7171_CR16","first-page":"641","volume":"37","author":"The Rheumatology Group of the Pediatrics Branch of the Chinese Medical Association, the Pediatrics Group of the Rheumatology and Immunology Branch of the Chinese Medical Association, the Children\u2019s Group of the Rheumatology and Immunology Professional Committee of the Cross Strait Medical and Health Exchange Association","year":"2022","unstructured":"The Rheumatology Group of the Pediatrics Branch of the Chinese Medical Association, the Pediatrics Group of the Rheumatology and Immunology Branch of the Chinese Medical Association, the Children\u2019s Group of the Rheumatology and Immunology Professional Committee of the Cross Strait Medical and Health Exchange Association. Expert consultation on clinical diagnosis and treatment of childhood systemic lupus erythematosus (2022 version). Chin J Practical Pediatr. 2022;37(9):641\u201352.","journal-title":"Chin J Practical Pediatr"},{"key":"7171_CR17","doi-asserted-by":"publisher","first-page":"940416","DOI":"10.3389\/fimmu.2022.940416","volume":"13","author":"F Chen","year":"2022","unstructured":"Chen F, Zheng Y, Chen X, et al. Belimumab in childhood systemic lupus erythematosus: a review of available data. Front Immunol. 2022;13:940416.","journal-title":"Front Immunol"},{"key":"7171_CR18","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2147\/DDDT.S216193","volume":"14","author":"M Guzman","year":"2020","unstructured":"Guzman M, Hui-Yuen JS. Management of pediatric systemic lupus erythematosus: focus on belimumab. Drug Des Devel Ther. 2020;14:2503\u201313.","journal-title":"Drug Des Devel Ther"},{"key":"7171_CR19","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.1016\/j.clim.2019.108274","volume":"209","author":"EMD Smith","year":"2019","unstructured":"Smith EMD, Lythgoe H, Midgley A, et al. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274.","journal-title":"Clin Immunol"},{"issue":"6","key":"7171_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.autrev.2017.04.011","volume":"16","author":"JF Le Kleinmann","year":"2017","unstructured":"Kleinmann JF, Tubach F, Le Guern V, et al. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmun Rev. 2017;16(6):650\u20137.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7171_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15\u201329.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7171_CR22","doi-asserted-by":"publisher","first-page":"103692","DOI":"10.1016\/j.autrev.2024.103692","volume":"24","author":"X He","year":"2025","unstructured":"He X, Hu B, Zhang Y, et al. Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells. Autoimmun Rev. 2025;24(1):103692.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"7171_CR23","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","volume":"79","author":"HI Brunner","year":"2020","unstructured":"Brunner HI, Abud-Mendoza C, Viola DO, et al. Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial. Ann Rheum Dis. 2020;79(10):1340\u20138.","journal-title":"Ann Rheum Dis"},{"key":"7171_CR24","doi-asserted-by":"publisher","first-page":"1067721","DOI":"10.3389\/fimmu.2022.1067721","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Shan C, Liu J, et al. Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study. Front Immunol. 2022;13:1067721.","journal-title":"Front Immunol"},{"key":"7171_CR25","unstructured":"Niu XL, Hao S, Kang YL et al. Clinical significance of early application of belimumab in the treatment of systemic lupus erythematosus in children. Chin J Practical Pediatr. 2023;38(8):561\u2013566."},{"issue":"9","key":"7171_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1177\/09612033231187752","volume":"32","author":"JE Roberts","year":"2023","unstructured":"Roberts JE, Burn C, Sadun RE, et al. Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective study. Lupus. 2023;32(9):1111\u20136.","journal-title":"Lupus"},{"issue":"7","key":"7171_CR27","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/art.40861","volume":"71","author":"DJ Wallace","year":"2019","unstructured":"Wallace DJ, Ginzler EM, Merrill JT, et al. Safety and efficacy of belimumab plus standard therapy for up to thirteen years in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(7):1125\u201334.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"7171_CR28","doi-asserted-by":"publisher","first-page":"e001747","DOI":"10.1136\/rmdopen-2021-001747","volume":"7","author":"HI Brunner","year":"2021","unstructured":"Brunner HI, Abud-Mendoza C, Mori M, et al. Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison. RMD Open. 2021;7(3):e001747.","journal-title":"RMD Open"},{"issue":"8","key":"7171_CR29","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/annrheumdis-2011-200937","volume":"71","author":"RF Van Vollenhoven","year":"2012","unstructured":"Van Vollenhoven RF, Petri MA, Cervera R, et al. Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Ann Rheum Dis. 2012;71(8):1343\u20139.","journal-title":"Ann Rheum Dis"},{"key":"7171_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.09.004","volume":"86","author":"L Iaccarino","year":"2018","unstructured":"Iaccarino L, Andreoli L, Bocci EB, et al. Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study. J Autoimmun. 2018;86:1\u20138.","journal-title":"J Autoimmun"},{"issue":"Suppl1","key":"7171_CR31","first-page":"45","volume":"82","author":"F Zhang","year":"2023","unstructured":"Zhang F, et al. A pivotal phase \u2162 study of belimumab in Asian SLE patients: Extended 5-year follow-up. Ann Rheum Dis. 2023;82(Suppl1):45\u201352.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07171-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:06:01Z","timestamp":1787882761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07171-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7171"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07171-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of Baoding Hospital, Beijing Children\u2019s Hospital, Capital Medical University (Approval No. 2024-40). Written informed consent was obtained from the legal guardians of all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"812"}}